Kim MJ - Search Results

1

Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07.

Kim ST, Kim SY, Lee J, Yun SH, Kim HC, Lee WY, Kim TW, Hong YS, Lim SB, Baek JY, Oh JH, Ahn JB, Shin SJ, Han SW, Kim SG, Kang SY, Sym SJ, Zang DY, Kim YH, Choi IS, Kang JH, Kim MJ, Park YS. Kim ST, et al. Among authors: kim yh, kim tw, kim sg, kim sy, kim hc, kim mj. J Clin Oncol. 2022 Nov 20;40(33):3868-3877. doi: 10.1200/JCO.21.02962. Epub 2022 Jun 30. J Clin Oncol. 2022. PMID: 35772045 Free PMC article. Clinical Trial.

2

Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis.

Lee YY, Kim TJ, Kim MJ, Kim HJ, Song T, Kim MK, Choi CH, Lee JW, Bae DS, Kim BG. Lee YY, et al. Among authors: kim hj, kim bg, kim tj, kim mj, kim mk. Gynecol Oncol. 2011 Sep;122(3):541-7. doi: 10.1016/j.ygyno.2011.05.009. Epub 2011 Jun 2. Gynecol Oncol. 2011. PMID: 21640372

3

Possible anticipation associated with a novel splice site mutation in episodic ataxia type 2.

Choi KD, Yook JW, Kim MJ, Kim HS, Park YE, Kim JS, Choi JH, Shin JH, Kim DS. Choi KD, et al. Among authors: kim ds, kim js, kim hs, kim mj. Neurol Sci. 2013 Sep;34(9):1629-32. doi: 10.1007/s10072-013-1298-8. Epub 2013 Jan 24. Neurol Sci. 2013. PMID: 23344743

4

Adherence to varenicline and abstinence rates for quitting smoking in a private health promotion center-based smoking cessation clinic.

Lee JY, Kim MJ, Jun HJ, Kang M, Park AR, Oh DE, Choi YH, Hwang JH. Lee JY, et al. Among authors: kim mj. Tuberc Respir Dis (Seoul). 2012 May;72(5):426-32. doi: 10.4046/trd.2012.72.5.426. Epub 2012 May 29. Tuberc Respir Dis (Seoul). 2012. PMID: 23101007 Free PMC article.

5

[Endoscopic Management of Dysphagia].

Kim MJ, Min YW. Kim MJ, et al. Korean J Gastroenterol. 2021 Feb 25;77(2):77-83. doi: 10.4166/kjg.2021.025. Korean J Gastroenterol. 2021. PMID: 33632998 Free article. Review. Korean.

6

Radiologic response to transcatheter hepatic arterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma.

Kim CJ, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI, Kim MJ. Kim CJ, et al. Among authors: kim hj, kim bi, kim mj. Liver Int. 2014 Feb;34(2):305-12. doi: 10.1111/liv.12270. Epub 2013 Jul 25. Liver Int. 2014. PMID: 23890360

7

Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells.

Kim MJ, Choi NY, Lee EK, Kang MS. Kim MJ, et al. Cell Oncol (Dordr). 2014 Aug;37(4):235-43. doi: 10.1007/s13402-014-0178-4. Epub 2014 Jul 8. Cell Oncol (Dordr). 2014. PMID: 25001871

8

Usefulness of phrenic latency and forced vital capacity in patients with ALS with latent respiratory dysfunction.

Kwon S, Min JH, Cho HJ, Joo BE, Cho EB, Seok JM, Kim MJ, Kim BJ. Kwon S, et al. Among authors: kim bj, kim mj. Clin Neurophysiol. 2015 Jul;126(7):1421-6. doi: 10.1016/j.clinph.2014.10.006. Epub 2014 Oct 12. Clin Neurophysiol. 2015. PMID: 25454281

9

Hepatoid carcinoma of the ovary without staining for alpha-fetoprotein.

Sung JH, Kim TH, Park HG, Kim MJ, Kim BG, Kim TJ, Bae DS. Sung JH, et al. Among authors: kim th, kim bg, kim tj, kim mj. Obstet Gynecol Sci. 2013 Jan;56(1):41-4. doi: 10.5468/OGS.2013.56.1.41. Epub 2013 Jan 9. Obstet Gynecol Sci. 2013. PMID: 24327979 Free PMC article.

10

Safety evaluation and risk assessment of d-Limonene.

Kim YW, Kim MJ, Chung BY, Bang du Y, Lim SK, Choi SM, Lim DS, Cho MC, Yoon K, Kim HS, Kim KB, Kim YS, Kwack SJ, Lee BM. Kim YW, et al. Among authors: kim kb, kim ys, kim hs, kim mj. J Toxicol Environ Health B Crit Rev. 2013;16(1):17-38. doi: 10.1080/10937404.2013.769418. J Toxicol Environ Health B Crit Rev. 2013. PMID: 23573938 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,847 results

Search Page